Outcomes of Infectious Endophthalmitis in Patients with Systemic Antibiotic Allergies to Penicillins, Cephalosporins, or Vancomycin

Macular Diseases

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Ophthalmology.

Daien V, Nguyen V, Essex RW, Morlet N, Barthelmes D, Gillies MC; Fight Retinal Blindness! Study Group

doi: 10.1016/

Retinal Diseases

VISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two

Retina.

Soliman MK, Gini G, Kuhn F, Parolini B, Ozdek S, Adelman RA, Sallam AB, European Vitreo-Retinal Society (EVRS) Endophthalmitis Study Group.

doi: 10.1097/IAE.0000000000002856.

RECOMMENDED

Further Publications

Endophthalmitis prophylaxis failures in patients injected with intracameral antibiotic during cataract surgery

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

Am J Ophthalmol

Shorstein NH, Liu L, Carolan JA, Herrinton L

doi: 10.1016/j.ajo.2021.02.007

Uveitis

Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis

JAMA.

Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA

doi: 10.1001/

Cornea and Corneal DiseasesSurgery and Intervention

Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty

Am J Ophthalmol.

Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK, Raber IM, Rapuano CJ, Syed ZA

doi: 10.1016/j.ajo.2019.05.004.

COMMENTED

Macular Diseases

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

★ 2 Recommended and commented by Prof. Dr Stephan Michels, Faculty Member

BMC Ophthalmol.

Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Sakamoto T, Wong TY, Pantiri K, Carrasco J

doi: 10.1186/s12886-020-01554-2.

UveitisFurther Publications

The association between non-infectious uveitis and COVID-19 outcomes: an analysis of United States claims-based data

Ophthalmology

Miller DC, Sun Y, Chen EM, Arnold BF, Acharya NR

doi: 10.1016/j.ophtha.2021.10.007

Uveitis

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Lancet.

Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brézin AP

doi: 10.1016/

Ocular Oncology

Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy

JAMA Ophthalmol.

Shields CL, Sioufi K, Srinivasan A, DiNicola M, Masoomian B, Barna LE, Bekerman VP, Say EAT, Mashayekhi A, Emrich J, Komarnicky L, Shields JA

doi: 10.1001/jamaophthalmol.

Related content